🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, mono-center phase I/II study designed to determine t...
Status
Unknown
Location
Charité, university medicine, Berlin, CCM
Start Date
2009-02
Trial ID
NCT00930475
RATIONALE: Everolimus may stop the growth of tumor cells by blocking some o...
Status
Terminated
Location
University of California Davis Cancer Center
Start Date
2009-03
Trial ID
NCT00807755
Treatments Being Tested
This 2 step study aims to establish a tolerable dose level and regimen of R...
Status
Completed
Location
Georgetown University/Lombardi Cancer Center StudyCoordinator:CRAD001C2114
Start Date
2007-02
Trial ID
NCT00457119
Treatments Being Tested
The purpose of this study is to test the drug RAD001 in combination with an...
Status
Completed
Location
Emory University Hospital Midtown
Start Date
2012-02
Trial ID
NCT01490749
Treatments Being Tested
Based on data demonstrating synergy between paclitaxel and mammalian target...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2010-02
Trial ID
NCT01014351
Treatments Being Tested
The purpose of this study is to test the drug RAD001 in combination with ot...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2011-01
Trial ID
NCT01283334
Treatments Being Tested
1.Phase I: To estimate the Maximum Tolerated Dose (MTD) of RAD001 in combin...
Status
Terminated
Location
Johns Hopkins University
Start Date
2009-10
Trial ID
NCT01009346
Treatments Being Tested
This phase Ib trial determines if samples from a patient's cancer can be te...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2020-04-01
Trial ID
NCT03878524
Treatments Being Tested
This is a multi-centric, open-label study evaluating the efficacy and safet...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04
Trial ID
NCT01317615
Treatments Being Tested